Alcentra Capital (NASDAQ:ABDC) Stock Rating Lowered by ValuEngine

Alcentra Capital (NASDAQ:ABDC) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Thursday, ValuEngine reports.

Shares of NASDAQ ABDC traded up $0.04 during midday trading on Thursday, reaching $8.35. 8,870 shares of the stock traded hands, compared to its average volume of 34,441. The company has a market capitalization of $107.16 million, a PE ratio of 8.27 and a beta of 0.62. Alcentra Capital has a one year low of $5.58 and a one year high of $8.74. The stock has a 50 day moving average of $8.39.

Alcentra Capital (NASDAQ:ABDC) last posted its earnings results on Monday, May 6th. The asset manager reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $6.43 million during the quarter, compared to the consensus estimate of $6.24 million. Alcentra Capital had a return on equity of 8.84% and a net margin of 14.50%. Analysts anticipate that Alcentra Capital will post 0.81 earnings per share for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Pacific Ridge Capital Partners LLC lifted its position in Alcentra Capital by 1.5% in the first quarter. Pacific Ridge Capital Partners LLC now owns 445,952 shares of the asset manager’s stock worth $3,345,000 after buying an additional 6,794 shares during the last quarter. Globeflex Capital L P increased its stake in Alcentra Capital by 18.5% in the first quarter. Globeflex Capital L P now owns 127,838 shares of the asset manager’s stock worth $959,000 after purchasing an additional 19,932 shares during the period. Two Sigma Investments LP purchased a new stake in Alcentra Capital in the fourth quarter worth $265,000. LSV Asset Management increased its stake in Alcentra Capital by 1,814.8% in the first quarter. LSV Asset Management now owns 39,540 shares of the asset manager’s stock worth $296,000 after purchasing an additional 37,475 shares during the period. Finally, Oppenheimer & Co. Inc. increased its stake in Alcentra Capital by 226.1% in the first quarter. Oppenheimer & Co. Inc. now owns 33,257 shares of the asset manager’s stock worth $249,000 after purchasing an additional 23,059 shares during the period. Institutional investors own 35.65% of the company’s stock.

Alcentra Capital Company Profile

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

Recommended Story: How interest rates affect municipal bond prices

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.